Clinical study of different doses of atorvastatin combined with febuxostat in patients with gout and carotid atherosclerosis

To evaluate the efficacy of atorvastatin combined with febuxostat in the treatment of gout patients with carotid atherosclerosis and to observe the effects on serum tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and C-reactive protein (CRP) levels, carotid plaques, and the adverse reaction...

Full description

Saved in:
Bibliographic Details
Published in:Pakistan journal of medical sciences 2020-10, Vol.36 (6), p.1334-1338
Main Authors: Zhang, Zheng, Xu, Ming-Hua, Wei, Feng-Ju, Shang, Li-Na
Format: Article
Language:English
Subjects:
Antilipemic agents
Arthritis
Atherosclerosis
Care and treatment
Carotid arteries
Chronic illnesses
Chronic kidney failure
Clinical trials
Cytokines
Disease
Febuxostat
Females
Gout
Inflammation
Metabolism
Original
Patients
Physiological aspects
Rheumatism
Risk factors
Smooth muscle
Software
Tumor necrosis factor-TNF
Ultrasonic imaging
Uric acid
Veins & arteries
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To evaluate the efficacy of atorvastatin combined with febuxostat in the treatment of gout patients with carotid atherosclerosis and to observe the effects on serum tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and C-reactive protein (CRP) levels, carotid plaques, and the adverse reactions. Seventy patients with gout and carotid atherosclerosis admitted to Affiliated Hospital of Hebei University from January 2014 to June 2017 were randomly divided into a treatment group and a control group. The treatment group received oral febuxostat 40 mg/day combined with atorvastatin 40 mg/day. The control group was given 40 mg/day febuxostat combined with 20 mg/day atorvastatin for 90 days. The effects of treatment on TNF-α, IL-1β, and CRP levels and carotid plaques of the patients were observed. After 90 days of treatment, serum TNF-α, IL-1β, and CRP levels, as well as HUA and total cholesterol (TC), decreased in both groups after treatment. There were significant differences observed (p < 0.05). The carotid artery plaques in the two groups were significantly smaller after treatment (P 0.05). Double doses of atorvastatin combined with febuxostat can effectively reduce uric acid to improve the inflammatory state in patients and reduce carotid plaques without increasing the incidence of adverse reactions.
ISSN:1682-024X
1681-715X
DOI:10.12669/pjms.36.6.2945